ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,328,000 | +39.3% | 93,400 | -26.6% | 0.25% | +33.3% |
| Q1 2019 | $3,106,000 | +19.5% | 127,300 | -30.3% | 0.19% | +6.9% |
| Q4 2018 | $2,599,000 | -1.0% | 182,600 | +5.8% | 0.17% | +55.4% |
| Q3 2018 | $2,624,000 | +27.5% | 172,600 | +40.8% | 0.11% | +16.7% |
| Q2 2018 | $2,058,000 | +4.6% | 122,600 | +1.7% | 0.10% | -2.0% |
| Q1 2018 | $1,968,000 | +4.1% | 120,600 | -18.3% | 0.10% | +6.5% |
| Q4 2017 | $1,890,000 | -60.3% | 147,664 | -61.8% | 0.09% | -60.5% |
| Q3 2017 | $4,759,000 | +44.1% | 386,900 | -1.9% | 0.23% | +45.6% |
| Q2 2017 | $3,302,000 | +203.5% | 394,400 | +223.8% | 0.16% | +146.2% |
| Q1 2017 | $1,088,000 | +1136.4% | 121,800 | +1118.0% | 0.06% | +1200.0% |
| Q4 2016 | $88,000 | -78.4% | 10,000 | -83.4% | 0.01% | -75.0% |
| Q3 2016 | $407,000 | +192.8% | 60,200 | +55.6% | 0.02% | +122.2% |
| Q2 2016 | $139,000 | -21.5% | 38,700 | -35.5% | 0.01% | -18.2% |
| Q1 2016 | $177,000 | -80.0% | 60,000 | -71.4% | 0.01% | -79.2% |
| Q4 2015 | $886,000 | +238.2% | 210,000 | +265.2% | 0.05% | +253.3% |
| Q3 2015 | $262,000 | +263.9% | 57,500 | +475.0% | 0.02% | +400.0% |
| Q2 2015 | $72,000 | -83.7% | 10,000 | -83.3% | 0.00% | -86.4% |
| Q1 2015 | $442,000 | +3.8% | 60,000 | -33.3% | 0.02% | +4.8% |
| Q4 2014 | $426,000 | – | 90,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |